Nonoperating Income (Expense) in USD of BIOXYTRAN, INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bioxytran, Inc quarterly/annual Nonoperating Income (Expense) history and change rate from Q2 2010 to Q3 2025.
  • Bioxytran, Inc Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $213K.
  • Bioxytran, Inc Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was -$630K, a 328% decline year-over-year.
  • Bioxytran, Inc annual Nonoperating Income (Expense) for 2024 was -$157K, a 79.4% increase from 2023.
  • Bioxytran, Inc annual Nonoperating Income (Expense) for 2023 was -$763K, a 232% decline from 2022.
  • Bioxytran, Inc annual Nonoperating Income (Expense) for 2022 was -$230K, a 26.7% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

BIOXYTRAN, INC Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$630K $213K +$259K 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$889K $260K +$312K 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 -$1.2M -$838K -$1.04M -508% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$157K -$264K -$9.8K -3.86% 01 Oct 2024 31 Dec 2024 10-K 03 Apr 2025
Q3 2024 -$147K -$46.2K +$4.33K +8.58% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$151K -$52.3K +$338K +86.6% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 -$489K $205K +$273K 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$763K -$254K -$483K -211% 01 Oct 2023 31 Dec 2023 10-K 03 Apr 2025
Q3 2023 -$280K -$50.5K +$167K +76.8% 01 Jul 2023 30 Sep 2023 10-Q 03 Nov 2023
Q2 2023 -$447K -$390K -$293K -303% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$153K -$67.7K +$76.5K +53.1% 01 Jan 2023 31 Mar 2023 10-Q 19 Apr 2024
Q4 2022 -$230K $229K +$291K 01 Oct 2022 31 Dec 2022 10-K/A 13 Jan 2025
Q3 2022 -$521K -$217K -$155K -248% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 -$366K -$96.8K +$4.5K +4.45% 01 Apr 2022 30 Jun 2022 10-Q 31 Jul 2023
Q1 2022 -$370K -$144K -$56.9K -65.1% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$314K -$62.4K +$32.7K +34.3% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$346K -$62.4K +$25.2K +28.7% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$371K -$101K +$715K +87.6% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$1.09M -$87.4K +$187K +68.2% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q4 2020 -$1.27M -$95.1K +$22.5K +19.2% 01 Oct 2020 31 Dec 2020 10-K 11 Apr 2022
Q3 2020 -$1.3M -$87.6K -$63.8K -268% 01 Jul 2020 30 Sep 2020 10-Q 17 Nov 2021
Q2 2020 -$1.23M -$817K -$793K -3332% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 -$440K -$274K -$213K -344% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$227K -$118K 01 Oct 2019 31 Dec 2019 10-K 09 Apr 2021
Q3 2019 -$23.8K 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$23.8K 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q1 2019 -$61.8K 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q3 2017 -$7.8K -$1.95K $0 0% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 -$7.8K -$1.95K +$17.7K +90.1% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 -$25.5K -$1.95K $0 0% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017
Q4 2016 -$25.5K -$1.95K +$98.00 +4.79% 01 Oct 2016 31 Dec 2016 10-K 31 Mar 2017
Q3 2016 -$25.6K -$1.95K +$9.00 +0.46% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 -$25.6K -$19.6K -$17.7K -909% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$7.9K -$1.95K -$102 -5.52% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$7.8K -$2.05K +$57.2K +96.5% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$65K -$1.96K -$9 -0.46% 01 Jul 2015 30 Sep 2015 10-Q 09 Dec 2016
Q2 2015 -$65K -$1.95K +$50.00 +2.51% 01 Apr 2015 30 Jun 2015 10-Q 20 Sep 2016
Q1 2015 -$65.1K -$1.85K +$1.13K +37.8% 01 Jan 2015 31 Mar 2015 10-Q 20 Sep 2016
Q4 2014 -$66.2K -$59.3K -$264K -129% 01 Oct 2014 31 Dec 2014 10-K 20 Sep 2016
Q3 2014 $198K -$1.95K +$193 +9.01% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 $197K -$2K +$5.39K +73% 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015
Q1 2014 $192K -$2.97K -$1.89K -174% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2014
Q4 2013 $194K $205K +$215K 01 Oct 2013 31 Dec 2013 10-K 10 Apr 2015
Q3 2013 -$20.6K -$2.14K -$1.11K -106% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$19.5K -$7.39K -$6.35K -613% 31 Mar 2013 30 Jun 2013 10-Q 12 Aug 2014
Q1 2013 -$13.1K -$1.09K -$9.58K -113% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q4 2012 -$3.55K -$9.97K -$14.7K -311% 01 Oct 2012 31 Dec 2012 10-K 14 Apr 2014
Q3 2012 $11.2K -$1.04K -$3.09K -151% 01 Jul 2012 30 Sep 2012 10-Q 18 Nov 2013
Q2 2012 $14.2K -$1.04K +$6.17K +85.6% 31 Mar 2012 30 Jun 2012 10-Q 15 Aug 2013
Q1 2012 $8.07K $8.5K +$12.5K 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$4.4K $4.73K 01 Oct 2011 31 Dec 2011 10-K 15 Apr 2013
Q3 2011 $2.05K +$3.67K 01 Jul 2011 30 Sep 2011 10-Q/A 31 Dec 2012
Q2 2011 -$7.21K -$5.22K -263% 01 Apr 2011 30 Jun 2011 10-Q/A 22 Jan 2013
Q1 2011 -$3.97K 01 Jan 2011 31 Mar 2011 10-Q/A 22 Jan 2013
Q3 2010 -$1.61K 01 Jul 2010 30 Sep 2010 10-Q/A 31 Dec 2012
Q2 2010 -$1.99K 01 Apr 2010 30 Jun 2010 10-Q/A 31 Dec 2012

BIOXYTRAN, INC Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$157K +$606K +79.4% 01 Jan 2024 31 Dec 2024 10-K 03 Apr 2025
2023 -$763K -$533K -232% 01 Jan 2023 31 Dec 2023 10-K 03 Apr 2025
2022 -$230K +$83.6K +26.7% 01 Jan 2022 31 Dec 2022 10-K/A 13 Jan 2025
2021 -$314K +$960K +75.4% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$1.27M -$1.05M -461% 01 Jan 2020 31 Dec 2020 10-K 11 Apr 2022
2019 -$227K -$146K -179% 01 Jan 2019 31 Dec 2019 10-K 09 Apr 2021
2018 -$81.3K 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2020
2016 -$25.5K -$17.7K -227% 01 Jan 2016 31 Dec 2016 10-K 31 Mar 2017
2015 -$7.8K +$58.4K +88.2% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$66.2K -$260K -134% 01 Jan 2014 31 Dec 2014 10-K 20 Sep 2016
2013 $194K +$197K 01 Jan 2013 31 Dec 2013 10-K 10 Apr 2015
2012 -$3.55K +$849 +19.3% 01 Jan 2012 31 Dec 2012 10-K 14 Apr 2014
2011 -$4.4K +$3.04K +40.9% 01 Jan 2011 31 Dec 2011 10-K 15 Apr 2013
2010 -$7.44K 01 Jan 2010 31 Dec 2010 10-K/A 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.